Breast 0 6 0 6 B-cancer
cancer 7 13 7 13 I-cancer
patients 14 22 14 22 O
identified 23 33 23 33 O
as 34 36 34 36 O
conservation 37 49 37 49 O
candidates 50 60 50 60 O
by 61 63 61 63 O
their 64 69 64 69 O
surgeons 70 78 70 78 O

Newly 0 5 79 84 O
diagnosed 6 15 85 94 O
breast 16 22 95 101 B-cancer
cancer 23 29 102 108 I-cancer
patients 30 38 109 117 O

Patients 0 8 118 126 O
who 9 12 127 130 O
receive 13 20 131 138 O
neoadjuvant 21 32 139 150 B-treatment
chemotherapy 33 45 151 163 I-treatment

Patients 0 8 164 172 O
who 9 12 173 176 O
weigh 13 18 177 182 O
more 19 23 183 187 O
than 24 28 188 192 O
350 29 32 193 196 B-lower_bound
pounds 33 39 197 203 I-lower_bound
( 40 41 204 205 O
weight 41 47 205 211 O
limit 48 53 212 217 O
on 54 56 218 220 O
MRI 57 60 221 224 B-treatment
machine 61 68 225 232 O
) 68 69 232 233 O

Patients 0 8 234 242 O
with 9 13 243 247 O
a 14 15 248 249 O
history 16 23 250 257 O
of 24 26 258 260 O
prior 27 32 261 266 B-treatment
breast 33 39 267 273 I-treatment
cancer 40 46 274 280 I-treatment
treatment 47 56 281 290 I-treatment
( 57 58 291 292 O
recurrence 58 68 292 302 O
) 68 69 302 303 O

Patients 0 8 304 312 O
with 9 13 313 317 O
breast 14 20 318 324 B-cancer
cancer 21 27 325 331 I-cancer
diagnosis 28 37 332 341 O
during 38 44 342 348 O
pregnancy 45 54 349 358 B-pregnancy
( 55 56 359 360 O
women 56 61 360 365 B-gender
who 62 65 366 369 O
could 66 71 370 375 O
bear 72 76 376 380 O
children 77 85 381 389 O
must 86 90 390 394 O
have 91 95 395 399 O
a 96 97 400 401 O
negative 98 106 402 410 B-pregnancy
pregnancy 107 116 411 420 I-pregnancy
test 117 121 421 425 O
before 122 128 426 432 O
beginning 129 138 433 442 O
this 139 143 443 447 O
study 144 149 448 453 O
) 149 150 453 454 O

Patients 0 8 455 463 O
with 9 13 464 468 O
documented 14 24 469 479 O
sensitivity 25 36 480 491 O
to 37 39 492 494 O
gadolinium 40 50 495 505 B-allergy_name
( 51 52 506 507 O
contrast 52 60 507 515 O
agent 61 66 516 521 O
used 67 71 522 526 O
during 72 78 527 533 O
MRI 79 82 534 537 B-treatment
) 82 83 537 538 O

Patients 0 8 539 547 O
with 9 13 548 552 O
renal 14 19 553 558 B-chronic_disease
insufficiency 20 33 559 572 I-chronic_disease
( 34 35 573 574 O
serum 35 40 574 579 B-clinical_variable
Cr 41 43 580 582 I-clinical_variable
> 44 45 583 584 O
1.5 46 49 585 588 B-lower_bound
) 49 50 588 589 O
due 51 54 590 593 O
to 55 57 594 596 O
the 58 61 597 600 O
danger 62 68 601 607 O
of 69 71 608 610 O
nephrogenic 72 83 611 622 B-chronic_disease
systemic 84 92 623 631 I-chronic_disease
sclerosis 93 102 632 641 I-chronic_disease
with 103 107 642 646 O
the 108 111 647 650 O
administration 112 126 651 665 O
of 127 129 666 668 O
Gadolinium 130 140 669 679 B-treatment

